期刊
NATURE COMMUNICATIONS
卷 9, 期 -, 页码 -出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/s41467-018-06769-y
关键词
-
资金
- Alfred Benzon Foundation
- Lundbeck Foundation
- Novo Nordisk Foundation
- European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program [694968]
- Alexander von Humboldt Foundation
- Helmholtz Alliance ICEMED
- Initiative and Networking Fund of the Helmholtz Association
- Helmholtz initiative on Personalized Medicine iMed
- German Research Foundation [DFG-TRR152-TP23]
- HGF/ExNet project Innovative Intelligent Imaging (i3-Helmholtz)
- Helmholtz cross-program Metabolic Dysfunction
Pharmacological stimulation of brown adipose tissue (BAT) thermogenesis to increase energy expenditure is progressively being pursued as a viable anti-obesity strategy. Here, we report that pharmacological activation of the cold receptor transient receptor potential cation channel subfamily M member 8 (TRPM8) with agonist icilin mimics the metabolic benefits of cold exposure. In diet-induced obese (DIO) mice, treatment with icilin enhances energy expenditure, and decreases body weight, without affecting food intake. To further potentiate the thermogenic action profile of icilin and add complementary anorexigenic mechanisms, we set out to identify pharmacological partners next to icilin. To that end, we specifically targeted nicotinic acetylcholine receptor (nAChR) subtype alpha3beta4 (alpha 3 beta 4), which we had recognized as a potential regulator of energy homeostasis and glucose metabolism. Combinatorial targeting of TRPM8 and nAChR alpha 3 beta 4 by icilin and dimethylphenylpiperazinium (DMPP) orchestrates synergistic anorexic and thermogenic pathways to reverse diet-induced obesity, dyslipidemia, and glucose intolerance in DIO mice.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据